15 trials changed in the last 30 days: 0 stopped, 2 with notable changes, 13 with minor changes only.
Recruitment opened
Astellas Pharma Global Development, Inc.Phase 1 NCT07783282 Registry history of NCT07783282 on ClinicalTrials.gov (opens the registry)
Recruitment opened
Astellas Pharma Global Development, Inc.Phase 1 NCT07773129 Registry history of NCT07773129 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Also in this update: Trial sites reduced: 54 → 47 locations; and 1 more change in the last 30 days
Astellas Pharma Global Development, Inc.Phase 3 NCT05970172 Registry history of NCT05970172 on ClinicalTrials.gov (opens the registry)
Trial completed
Astellas Pharma Global Development, Inc.Phase 3 NCT05621616 Registry history of NCT05621616 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Aug 31, 2026 to Oct 31, 2026
Astellas Pharma Global Development, Inc.Phase 2 NCT03816163 Registry history of NCT03816163 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Jul 31, 2026 to Dec 31, 2026
Astellas Pharma Global Development, Inc.Phase 1 NCT06396091 Registry history of NCT06396091 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Also in this update: Trial sites reduced: 65 → 58 locations
Astellas Pharma Global Development, Inc.Not specified NCT06779773 Registry history of NCT06779773 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 19 → 26 locations
And 1 more change in the last 30 days
Astellas Pharma Global Development, Inc.Phase 3 NCT07566156 Registry history of NCT07566156 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 17 → 22 locations
Astellas Pharma Global Development, Inc.Phase 3 NCT07566052 Registry history of NCT07566052 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 62 → 79 locations
Astellas Pharma Global Development, Inc.Phase 3 NCT07409272 Registry history of NCT07409272 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 33 → 48 locations
Astellas Pharma Global Development, Inc.Phase 2 NCT07475806 Registry history of NCT07475806 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 17 → 21 locations
Astellas Pharma Global Development, Inc.Phase 1/2 NCT07488676 Registry history of NCT07488676 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 13 → 22 locations
Astellas Pharma Global Development, Inc.Phase 1 NCT05997615 Registry history of NCT05997615 on ClinicalTrials.gov (opens the registry)
Study completion pushed from Sep 30, 2026 to Mar 31, 2027
Astellas Pharma Global Development, Inc.Phase 3 NCT03653507 Registry history of NCT03653507 on ClinicalTrials.gov (opens the registry)
Study completion pushed from Sep 30, 2026 to Mar 31, 2027
Astellas Pharma Global Development, Inc.Phase 2 NCT04225117 Registry history of NCT04225117 on ClinicalTrials.gov (opens the registry)
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-09-21 | NCT07829757 A Study of Zolbetuximab Given With mFOLFOX6 or CAPOX Chemotherapy in Indian Adults With… | Phase 4 | Not Yet Recruiting |
| Phase 1 | 12 | |
| Phase 1/2 | 6 | |
| Phase 2 | 6 | |
| Phase 3 | 10 | |
| Phase 4 | 2 |
Gastric Cancer (8) · Lung Cancer (7) · Pancreatic Cancer (7) · Non-Small Cell Lung Cancer (NSCLC) (6) · Prostate Cancer (6) · Bladder Cancer (4) · Breast Cancer (2) · Cholangiocarcinoma (2) · Esophageal Cancer (2) · Head & Neck Cancer (2)